Suzanne L Tomchuck

Title: Suzanne L Tomchuck: Innovator in Vaccine Development

Introduction

Suzanne L Tomchuck is a notable inventor based in Memphis, TN (US). She has made significant contributions to the field of vaccine development, particularly through her innovative research involving primary mesenchymal stem cells.

Latest Patents

Suzanne holds a patent for "Primary mesenchymal stem cells as a vaccine platform." This patent describes a method where episomally transfected primary mesenchymal stem cells (MSC) express a polypeptide consisting of an antigenic polypeptide related to a pathogen. The antigenic polypeptide can either have the amino acid sequence of a natural polypeptide from the pathogen or differ from the natural sequence by one or more conservative amino acid substitutions. The patent also outlines the uses and methods for treating or preventing infections with these episomally transfected primary MSC.

Career Highlights

Suzanne is affiliated with The Administrators of the Tulane Educational Fund, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of vaccine platforms and their applications in infectious disease prevention.

Collaborations

Suzanne collaborates with esteemed colleagues, including Elizabeth Bray Norton and Robert F Garry, who contribute to her research initiatives and enhance the impact of her work.

Conclusion

Suzanne L Tomchuck is a pioneering inventor whose work in vaccine development showcases the potential of primary mesenchymal stem cells. Her contributions are vital in the ongoing fight against infectious diseases, and her innovative spirit continues to inspire advancements in the field.